Dr. Guido Giunti, leader of the digital therapeutics research group at the University of Oulu and adjunct professor at Trinity College Dublin, discusses patient involvement and the necessity of being forward-thinking while creating digital therapeutics.
Q&A: Creating digital therapeutics for patient impact and profitability
